Search for companies, drugs, and catalysts
Phase 2
Development Phase
1
Upcoming Catalysts
0
Historical Events
Regulatory Approvals
SAR444200 Phase 2 Results Expected
SAR444200 • Neoplasm
Target Indication
Neoplasm
Clinical Trial
Last updated: 12/4/2025
SAN.PA
Sanofi